HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Bladder cancer

Bladder cancer is a type of cancer that begins in the cells of the bladder, a hollow organ in the pelvic area responsible for storing urine. It is a condition where abnormal cell growth occurs in the lining of the bladder. This form of cancer is more prevalent in older adults, with the majority of cases diagnosed in individuals over the age of 55. However, bladder cancer can affect people of any age. Smoking is a significant risk factor for developing bladder cancer, and other risk factors include exposure to certain chemicals and a family history of the disease. Symptoms of bladder cancer may include blood in the urine, pain during urination, and frequent urination. However, these symptoms can also be indicative of other non-cancerous conditions, making it important to consult a healthcare professional for a proper diagnosis. Diagnosis often involves a combination of medical history review, physical examination, and various tests such as imaging studies and urine analysis. Treatment options for bladder cancer depend on the stage of the disease and may include surgery, chemotherapy, immunotherapy, and radiation therapy.
As with many cancers, early detection and intervention play a crucial role in improving outcomes. Regular check-ups and screenings are essential, especially for individuals with risk factors. Bladder cancer, like any medical condition, requires personalized medical attention, and individuals are encouraged to consult with healthcare professionals to determine the most appropriate course of action based on their specific circumstances.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp